• Suppr超能文献
  • 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
定价套餐&价格
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Win 客户端微信小程序
定价
会员套餐积分包API 积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026
  1. 首页
  2. 分享广场
  3. 胶原蛋白肽是智商税?科学证据和临床数据告诉你真相

胶原蛋白肽是智商税?科学证据和临床数据告诉你真相

文献检索郑建光发表于 2026年10月02日 11:180阅读
检索问题

胶原蛋白肽是否是智商税

胶原蛋白肽绝对不是“智商税”,它对人体健康和皮肤改善确实有实质性的科学依据支持,但前提是要理性看待它的作用——它不是返老还童的仙丹,而是一种有明确生理活性的营养补充成分。

很多人觉得胶原蛋白肽是智商税,主要是因为市面上宣传太夸张,加上早期人们觉得“吃胶原蛋白补胶原蛋白”就像“吃脑补脑”一样不靠谱。但近年的科学研究已经证实,吃下去的胶原蛋白肽并不是直接糊在脸上,而是会被身体吸收并给身体发送“合成信号”。下面我们从几个关键方面把这件事说清楚。

1. 吃胶原蛋白真的能吸收吗?

过去最大的质疑是:胶原蛋白是大分子,吃到肚子里会被消化成氨基酸碎片,根本没法直接长到皮肤上。这就好比你觉得吃下去的砖头不能直接变成墙壁。

但现在的科学发现,事情没那么简单。我们吃下去的胶原蛋白肽,有一部分会被消化,但还有一部分能以“短肽”(比如含有羟脯氨酸的三肽)的形式直接被肠胃吸收进入血液。实验发现,富含这种三肽的胶原蛋白肽(CTP),比普通大分子胶原蛋白肽的吸收效果更好。也就是说,身体确实能把这些“建筑材料的小半成品”运送到需要的地方。

2. 它对皮肤到底有没有用?

有用,而且有临床数据支撑。胶原蛋白肽对皮肤的改善,主要是通过“派信使”和“调菌群”两种方式实现的。

第一,派信使:给皮肤下达“多生产胶原蛋白”的指令。 当胶原蛋白肽进入体内后,它们就像传令兵,会激活体内一条叫“TGF-β”(转化生长因子β)的信号通路。你可以把TGF-β通路理解成皮肤工厂的“生产开关”。这个开关一打开,皮肤自己合成胶原蛋白的速度就加快了。在皮肤胶原蛋白缺乏的小鼠实验中,补充特定胶原蛋白肽让皮肤里的胶原蛋白含量足足增加了119.95%!同时,它还能召唤身体里的“抗炎细胞”(如浆细胞)来干活,减少炎症对胶原蛋白的破坏。

第二,调菌群:通过肠道给皮肤送好处。 这也就是近年很火的“肠-皮轴”(肠道和皮肤的联系)。胶原蛋白肽中有一部分特别抗消化,能一路跑到大肠去充当“益生元”——也就是肠道好细菌的口粮。吃了这些口粮后,肠道里的好细菌(比如产短链脂肪酸的细菌)变多,产生的短链脂肪酸也增加。这些有益物质能进一步促进肠道里产生TGF-β的细胞,这些信号再传给皮肤,继续帮皮肤合成胶原蛋白。

第三,临床人群的实测结果。 光有动物实验不够,在真人身上同样测出了效果。一项针对东亚人群(85名43-65岁女性)的双盲对照测试中发现,每天吃5克胶原蛋白肽,仅仅28天,皮肤的弹性、皱纹情况、指甲色泽和整体的美丽观感就有明显改善;吃满84天(约3个月)后,皮肤内部的真皮层密度和水分也有了显著提升。另外,综合了805名患者的多项临床研究也表明,口服胶原蛋白补充剂能增加皮肤弹性、水合作用(保水能力)和真皮层胶原蛋白密度。如果和维生素C等搭配一起吃,效果可能更好。

3. 除了皮肤,它对身体还有什么好处?

胶原蛋白不仅脸上需要,关节、骨骼、伤口都需要。

帮助伤口愈合: 比如从罗非鱼皮中提取的胶原蛋白肽,在促进伤口愈合方面表现很抢眼。它们能刺激身体长出新的血管来送营养,调节炎症,还能促进皮肤重新长好。它们还能刺激身体产生更多用来修伤口的关键物质,比如血管内皮生长因子(VEGF)和成纤维细胞生长因子(FGF)。

保护骨骼和对抗骨质疏松: 骨骼里也有大量的胶原蛋白,它就像钢筋,钙就像水泥,光补钙没钢筋,骨头还是脆的。研究发现,把罗非鱼皮胶原蛋白肽和钙结合在一起做成“肽-钙螯合物”,补钙效果比吃普通的碳酸钙好得多。它能更好地促进肠道吸收钙,还能直接刺激成骨细胞(造骨头的细胞)干活,让骨头长得更密实。

减轻皮肤和身体的炎症: 从牦牛骨胶原蛋白里提取出的一种抗炎肽(名叫GR14),在实验中能显著减轻皮肤的炎症。在高剂量下,它让几种主要的炎症指标(如白细胞介素-6、肿瘤坏死因子-α等)下降了22%到40%不等。它的绝招是按住了体内一个叫“NF-κB”的炎症开关,还能把皮肤表面的微生态调整回正常状态。

对付组织纤维化(器官变硬的毛病): 纤维化就是身体某个器官长疤痕、变硬,失去功能。一种叫“卤夫酮”的抗纤维化药物,它的核心本领就是抑制I型胶原的合成。虽然这是药物不是普通补剂,但这从侧面证明:精准调控胶原蛋白的生成,是治疗器官变硬这类大病的关键思路。

4. 为什么有人觉得是智商税?避坑指南

既然有效,为啥还有人说没用?因为买错、吃错、期待错,都会让人觉得交了智商税。

  • 没吃够时间和剂量: 皮肤更新一个周期大概要28天以上,老了会更慢。吃几天就想皱纹消失是不可能的。临床有效剂量多在2.5克到10克/天,吃4到24周不等。
  • 产品纯度不够: 有些产品胶原蛋白肽没多少,加了一堆糖和香精,或者分子量没处理好,吸收率很差。
  • 误解了它的作用: 胶原蛋白肽是给身体提供“原料和信号”,它不能替代健康的生活方式。如果你天天熬夜、暴晒(紫外线是胶原蛋白杀手),吃再多胶原蛋白也补不回来漏洞。
  • 皮肤屏障本身有病: 目前对于一些皮肤屏障受损的疾病(比如特应性皮炎),胶原蛋白肽到底有没有用,研究还不够,不能指望它治大病。

总结

胶原蛋白肽不是智商税,它有扎实的吸收路径、明确的作用机制(激活TGF-β通路、调节肠道菌群)和临床数据支持(改善皮肤弹性、密度、伤口愈合和骨骼健康)。但它也不是魔法,它是一种需要持续补充、足量使用,并且配合健康生活习惯才能看到实效的营养成分。

References

1Orcinol glucoside ameliorates pulmonary fibrosis by suppressing hyaluronic acid synthesis and macrophage M2 polarization via targeting hyaluronic acid synthase 2.PubMed

Caizi Li, Xinglinzi Tang, Xiaoru Luo, et al.
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disorder characterized by unexplained fibrosis and limited therapeutic options, highlighting the urgent need for innovative treatments. Hyaluronic acid (HA), which is upregulated in IPF and correlates with disease severity, plays an undefined role in its pathogenesis. Hyaluronic acid synthase 2 (HAS2), a key enzyme in HA production, has an unclear function in IPF progression, particularly regarding its involvement in macrophage polarization. Understanding this mechanism is essential for identifying novel therapeutic targets and developing effective drugs for IPF. The present study investigated the roles of HAS2 and HA in IPF and identified potential therapeutic agents. Transcriptomic analysis revealed HAS2 as a critical IPF‑associated gene in patient samples, bleomycin (BLM)‑induced mouse models, and transforming growth factor β1 (TGF‑β1)‑induced myofibroblasts. Single‑cell RNA sequencing further confirmed the fibroblast‑specific upregulation of HAS2 in fibrotic lungs. Experimental validation showed elevated HAS2 expression and HA accumulation in fibrosis models. HA facilitated macrophage M2 polarization and TGF‑β1 secretion through CD44‑dependent STAT6 activation, with CD44 inhibition blocking this effect. Knockdown of HAS2 in fibroblasts decreased HA release and impaired their ability to promote M2 polarization, suggesting that fibroblast‑derived HA drives this process. High‑throughput virtual screening, coupled with absorption, distribution, metabolism and excretion (ADME) profiling, identified orcinol glucoside (OG) as a potential HAS2 inhibitor, which was validated through surface plasmon resonance, cellular thermal shift assays, and molecular dynamics simulations. OG suppressed HA synthesis in TGF‑β1‑induced and HAS2‑overexpressing myofibroblasts in a dose‑dependent manner, inhibiting M2 polarization induction. , OG reduced collagen deposition, HA, and TGF‑β1 levels in BLM‑induced fibrotic mice. These findings established HAS2 as a central pathogenic factor in IPF and suggested OG as a promising therapeutic candidate, providing a novel approach for IPF treatment by targeting HA synthesis and macrophage polarization.

2Collagen supplementation and regenerative health: advances in biomarker detection and smart material integration.PubMed

Tatjana Ivaskiene, Jonas Viskelis, Paulina Streimikyte, et al.
Collagen, the most abundant structural protein in the human body, plays a key role in skin integrity, tissue repair, and extracellular matrix organization. With increasing consumer and clinical interest, collagen supplementation has expanded rapidly, yet scientific evidence supporting its efficacy in anti-aging and regenerative applications remains inconsistent. This review critically evaluates current evidence on oral collagen supplementation, integrating insights from over 60 clinical studies assessing its effects on skin aging, musculoskeletal health, and hair disorders. Emerging data suggest that hydrolyzed collagen peptides may improve skin elasticity, joint function, and recovery after exercise, particularly when co-supplemented with vitamin C, silica, or resveratrol. Beyond supplementation, recent advances in biosensing and material science have enabled novel approaches to collagen detection and targeted delivery. Electrochemical, optical, and molecularly imprinted polymer (MIP)-based biosensors facilitate real-time monitoring of collagen biomarkers such as CTX-I, MMPs, and hydroxyproline, supporting precision assessment of collagen metabolism. In parallel, collagen-based hydrogels, nanoparticles, and electroresponsive scaffolds have shown promise as biocompatible carriers for controlled drug release and regenerative therapy. Collectively, these developments outline a translational framework connecting collagen supplementation, detection, and delivery. Continued integration of biosensing and smart material technologies may enhance clinical monitoring and therapeutic efficacy, advancing collagen-based interventions toward precision dermatology and regenerative medicine.

3Highlights of the 14th international mesothelioma interest group meeting: Pathologic separation of benign from malignant mesothelial proliferations and histologic/molecular analysis of malignant mesothelioma subtypes.PubMed

Andrew Churg, Kazuki Nabeshima, Greta Ali, et al.
OBJECTIVES: The separation of benign from malignant mesothelial proliferations and exact subclassification of mesothelioma subtypes is crucial to determining patient care and prognosis but morphologically can be very difficult. METHODS: This session of the 2018 IMIG meeting addressed these problems. RESULTS: A new immunohistochemical marker, methylthioadenosine phosphorylase, was shown to correlate well with CDKN2A FISH and is cheaper and faster to run. A 117 gene expression panel also provided good separation on both tissue biopsy and cytology samples. Review of a series of mesotheliomas thought to be biphasic produced only a moderate level of agreement among expert pathologists with some cases being classified as purely epithelioid or sarcomatoid; these classifications had prognostic significance. The entity called transitional mesothelioma was found to behave exactly like sarcomatoid mesothelioma. RNA-seq analysis of a large series of mesotheliomas from a public database showed that, genetically, the morphologic breakdown into epithelioid, sarcomatoid, or biphasic mesotheliomas is artificial because there is a continuous spectrum of genomic changes. There are now criteria for the diagnosis of mesothelioma in situ and this is potentially important, since such cases might be curable. CONCLUSIONS: This session documented new morphological and molecular approaches to separating benign from malignant mesothelial proliferations and to subclassifying malignant mesoteheliomas in clinical relevant ways.

4Epilepsy and related challenges in children with COL4A1 and COL4A2 mutations: A Gould syndrome patient registry.PubMed

Danielle Boyce, Sheena McGee, Lisa Shank, et al.
UNLABELLED: Recently, patient advocacy groups started using the name Gould syndrome to describe clinical features of COL4A1 and COL4A2 mutations. Gould syndrome is increasingly identified in genetic screening panels, and because it is a rare disease, there is a disproportionate burden on families to understand the disease and chart the course for clinical care. Among the chief concerns for caregivers of children with Gould syndrome are the challenges faced because of epilepsy, including severe manifestations such as infantile spasms. To document the concerns of the patient population, the Gould Syndrome Foundation established the Gould Syndrome Global Registry (GSGR). METHODS: The Gould Syndrome Foundation developed questions for the GSGR with iterative input from patients and caregivers. An institutional review board issued an exemption determination before data collection began. Participants were recruited through social media and clinician referrals. All participants consented electronically, and the data were collected and managed using REDCap electronic data capture tools. De-identified data representing responses received between October 2019 and February 2021 were exported and analyzed with IBM SPSS 27 using descriptive statistics (mean, standard deviation, frequency, range, and percent). RESULTS: Seventy families from twelve countries provided data for the registry, representing 100 affected people (40 adults and 60 children). This analysis represents a subanalysis of the 35 out of 60 children <=18 years of age who reported a history of seizures. Nearly half of these participants were diagnosed with infantile spasms. Participants with epilepsy frequently reported developmental delays (88.6%), stroke (60.0%), cerebral palsy (65.7%), and constipation (57.1%). Ten (28.6%) children use a feeding tube. Despite the fact that more than half of respondents reported stroke, only 34.3% reported ever receiving education on stroke recognition. CONCLUSION: Here we describe the development and deployment of the first global registry for individuals and family members with Gould syndrome, caused by mutations in COL4A1 and COL4A2. It is important for pediatric neurologists to have access to resources to provide families upon diagnosis. Specifically, all families with Gould Syndrome must have access to infantile spasms awareness and stroke education materials. The Gould Syndrome Foundation is planning several improvements to this patient registry which will encourage collaboration and innovation for the benefit of people living with Gould syndrome.

5A Systematic Review of the Effect of on Wound Healing.PubMed

Elena Arribas-López, Nazanin Zand, Omorogieva Ojo, et al.
BACKGROUND: Under metabolic stress conditions, there is a higher demand for nutrients which needs to be met. This is to reduce the risk of delay in wound healing which could lead to chronic wound. AIM: This is a systematic review of the effect of on wound healing. is a traditional medicinal plant used due to its antimicrobial, antioxidant, anti-inflammatory, neuroprotective, and wound healing properties. METHODS: PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines were followed for the systematic review and four electronic databases were used. RESULTS: Four clinical trials met the inclusion criteria. The following distinct areas were identified under : wound contraction and granulation; healing/bleeding time and re-epithelialization; VAS (visual analogue scale) scores; skin erythema and wound appearance. CONCLUSIONS: might enhance wound healing resulting from improved angiogenesis. This might occur due to its stimulating effect on collagen I, Fibroblast Growth Factor (FGF) and Vascular Endothelial Growth Factor (VEGF) production. Besides, has shown an anti-inflammatory effect observed by the reduction in Interleukin-1β (IL-1β), Interleukin-6 (IL-6) and Tumour Necrosis Factor α (TNFα), prostaglandin E2 (PGE2), cyclooxygenase-2 (COX-2), and lipoxygenase (LOX) activity. Delivery systems such as nanoencapsulation could be used to increase bioavailability. Nevertheless, more studies are needed in order to perform a meta-analysis and ascertain the effects of on wound healing and its different parameters.

6Tilapia skin collagen peptides‑calcium chelates:Structural characterization, stability, in vitro and in vivo anti-osteoporosis mechanism.PubMed

Xing Xie, Meng-Ting Zhang, Chun-Lin Huang, et al.
Tilapia (Oreochromis mossambicus) skin, as a by-product with high collagen, is an excellent source of calcium carriers to develop novel functional food for osteoporosis. In this study, tilapia skin collagen peptides (TSCP) were used to prepare peptides‑calcium chelates (TSCP-Ca), and the structural characteristics and stability were evaluated. The in vitro and in vivo anti-osteoporosis mechanisms of TSCP-Ca were investigated by Osteoblast hFoB1.19 cells and low calcium diet mice models. The results indicated that TSCP had high calcium chelating ability with value of 93.20 ± 1.23 mg/g, and NH and CO groups mainly participated in chelating calcium ions. TSCP-Ca showed favorable thermal and digestive stabilities. In vitro study demonstrated that TSCP-Ca could enhance calcium nodules formation and alkaline phosphatase (ALP) activity, and promote osteoblast differentiation by modulating OPG/RANKL and FGF2/RUNX2 signaling pathways in osteoblast hFoB1.19 cells. In vivo, TSCP-Ca significantly promoted calcium absorption and bone growth, improved femoral structure and density in calcium deficient mice, and the effect was significantly better than that of CaCO. Meanwhile, TSCP-Ca treatment could regulate bone metabolism by regulating the relative abundance of probiotics like Bifidobacterium, Bacteroides, Blautia, Alistipes based on gut-bone axis, resulting to the increase of calcium absorption and bone formation in calcium deficient mice. These findings suggested that TSCP-Ca could be applied as potential dietary supplement or calcium supplement for treating osteoporosis.

7Oral Collagen Supplementation: A Systematic Review of Dermatological Applications.PubMed

Franchesca D. Choi, Calvin T. Sung, Margit L.W. Juhasz, et al.
Importance: The use of nutraceuticals such as collagen for skincare has been rising, but regulations are lacking on quality, absorption, and efficacy. To address this knowledge gap, clinical studies regarding the potential effects of collagen-based dietary supplements on skin are being completed. Objective: To review the literature and assess available randomized-controlled trials using collagen supplementation for treatment efficacy regarding skin quality, anti-aging benefits, and potential application in medical dermatology. Evidence Review: A literature search was conducted with PubMed using search criteria (collagen) AND (supplement OR food OR nutrition). No lower limit on the year of publication was set. Inclusion criteria were: randomized, placebo-controlled trials using collagen supplementation in human subjects related to dermatology and written in English. Findings: Eleven studies with a total of 805 patients were included for review. Eight studies used collagen hydrolysate, 2.5g/d to 10g/d, for 8 to 24 weeks, for the treatment of pressure ulcers, xerosis, skin aging, and cellulite. Two studies used collagen tripeptide, 3g/d for 4 to 12 weeks, with notable improvement in skin elasticity and hydration. Lastly, one study using collagen dipeptide suggested anti-aging efficacy is proportionate to collagen dipeptide content. Conclusions and Relevance: Preliminary results are promising for the short and long-term use of oral collagen supplements for wound healing and skin aging. Oral collagen supplements also increase skin elasticity, hydration, and dermal collagen density. Collagen supplementation is generally safe with no reported adverse events. Further studies are needed to elucidate medical use in skin barrier diseases such as atopic dermatitis and to determine optimal dosing regimens. J Drugs Dermatol. 2019;18(1):9-16.

8Developments in the pharmacotherapeutic management of osteoporosis.PubMed

Pierre Close, Audrey Neuprez, Jean-Yves Reginster
During the last two decades, several medications have been granted a marketing authorisation for the management of osteoporosis. Bisphosphonates are the most widely prescribed drugs in this area, worldwide. Alendronate and risedronate are given daily or weekly and have demonstrated their ability to reduce fracture rates at the spine and hip. Ibandronate has demonstrated spine antifracture efficacy with intervals between dosings greater than weekly. New developments in this class include intravenous administration of ibandronate or zoledronate, once every three months or once yearly. Raloxifene, a selective estrogen-receptor modulator, reduces spine fractures and, in post-hoc analyses, non-spine fractures in high-risk subjects. New selective estrogen-receptor modulators, including lasofoxifene, bazedoxifene and arzoxifene, are expected to demonstrate antifracture efficacy at the hip level, whilst retaining the extra-skeletal benefits (such as in the breast) that are obtained with raloxifene. The peptides from the parathyroid hormone family are potent stimulators of bone formation. Teriparatide (1 - 34 amino acid fragment of the parathyroid hormone) reduces spine and non-spine fractures, an effect that is sustained for up to 30 months after the withdrawal of treatment. The intact hormone (1 - 84 amino acids) showed similar results on spine fractures, and more data are requested to evaluate its effect on non-spine or hip fractures. Strontium ranelate is suggested to be the first medication to uncouple bone formation from bone resorption. It has shown antifracture efficacy at all sites in a large number of postmenopausal women. New developments include: denosumab, an antibody against receptor activator of NF-kappaB ligand (RANKL); a cytokine that is responsible for osteoclastogenesis; and inhibitors of cathepsin K, a cysteine protease that is involved in the cleavage of collagen.

9The international dystrophic epidermolysis bullosa patient registry: an online database of dystrophic epidermolysis bullosa patients and their COL7A1 mutations.PubMed

Peter C van den Akker, Marcel F Jonkman, Trebor Rengaw, et al.
Dystrophic epidermolysis bullosa (DEB) is a heritable blistering disorder that can be inherited autosomal dominantly (DDEB) or recessively (RDEB) and covers a group of several distinctive phenotypes. A large number of unique COL7A1 mutations have been shown to underlie DEB. Although general genotype-phenotype correlation rules have emerged, many exceptions to these rules exist, compromising disease diagnosing and genetic counseling. We therefore constructed the International DEB Patient Registry (http://www.deb-central.org), aimed at worldwide collection and sharing of phenotypic and genotypic information on DEB. As of May 2011, this MOLGENIS-based registry contains detailed information on 508 published and 71 unpublished patients and their 388 unique COL7A1 mutations, and includes all combinations of mutations. The current registry RDEB versus DDEB ratio of 4:1, if compared to prevalence figures, suggests underreporting of DDEB in the literature. Thirty-eight percent of mutations stored introduce a premature termination codon (PTC) and 43% an amino acid change. Submission wizards allow users to quickly and easily share novel information. This registry will be of great help in disease diagnosing and genetic counseling and will lead to novel insights, especially in the rare phenotypes of which there is often lack of understanding. Altogether, this registry will greatly benefit the DEB patients.

10Evaluation of Nile Tilapia () Skin Peptides for Wound Healing: A Systematic and Meta-Analysis Review.PubMed

Rodrigo Tozetto, Julia B de Macedo, Thais Leticia M da Silva, et al.
Management of chronic wounds poses a significant challenge for medical teams worldwide, as it often requires prolonged hospitalization periods and frequently leaves sequelae, thereby becoming a public health problem. Furthermore, available medical treatments are usually ineffective for treating this type of injury; therefore, a survey for new treatments to achieve favorable outcomes is frequently sought. Among new treatment options for wound healing, the use of peptides extracted from the skin of Nile tilapia () has shown favorable results. The objective of this work was to evaluate the evidence demonstrating the effectiveness of Nile tilapia skin peptides (NTSP) in modulating cellular and molecular mechanisms involved in the wound healing process in animal models. A systematic review and meta-analysis were performed using the PubMed, SciELO, Web of Science, and EMBASE databases. Articles from 2014 to 2024 were selected using a combination of keywords (tilapia skin) AND (wound healing) AND (peptides), along with synonyms, according to the MeSH criteria. A total of 378 studies were identified, of which 16 were deemed relevant based on the inclusion and exclusion criteria. According to the studies analyzed, NTSP delivery systems led to a decrease in the wound healing period, stimulated blood vessel formation, regulated and mediated anti- and pro-inflammatory cytokines, and controlled infection. Syrcle's scale was used to assess the risk of bias, which was determined to be low. Additionally, the results from the meta-analysis demonstrate statistical significance in the findings from experiments utilizing NTSP. It is particularly evident in relation to wound retraction, wound closure, inflammatory score, and angiogenesis, indicating that the use of NTSP affects cellular and molecular mechanisms that stimulate the wound-healing process. However, significant heterogeneity was observed among the studies, which is a limitation of the analysis. Therefore, further clinical trials and standardized protocols are necessary to better elucidate the effects of NTSP.

11Novel Anti-Inflammatory Bioactive Peptide Derived from Yak Bone Collagen Alleviates the Skin Inflammation of Mice by Inhibiting the NF-κB Signaling Pathway and Modulating Skin Microbiota.PubMed

Zitao Guo, Tao Shi, Pengfei Xu, et al.
Food-derived anti-inflammatory bioactive peptides have garnered significant attention due to their wide sources, easy absorption, and high biosafety. Our preliminary study identified a novel anti-inflammatory peptide GPAGPSGPAGKDGR (GR14) from yak bone collagen, which significantly alleviates lipopolysaccharide-induced inflammatory responses in HaCaT cells, demonstrating potential applications in improving skin inflammation. The objective of this study is to validate the anti-inflammatory effects of GR14 at the skin level in living animals and elucidate its mechanism of action. In this study, a 1-chloro-2,4-dinitrobenzene (DNCB)-induced skin inflammation mouse model was established. Results indicated that the GR14 intervention significantly improved skin manifestations and serum inflammatory cytokine levels in model mice. Compared to the model group, the high-dose treatment group demonstrated 33.61%, 40.55%, 22.18%, and 31.25% reductions in interleukin-6, interleukin-1β, tumor necrosis factor-α, and nitric oxide levels, respectively. Western blotting confirmed that GR14 intervention significantly inhibited the phosphorylation levels of P65 and IκB in the NF-κB signaling pathway. Microbiota analysis revealed that GR14 intervention effectively restored the significant decreases in and abundances caused by DNCB stimulation, returning the skin microbiota structure to normal status. These findings suggested that GR14 alleviates skin inflammation in model mice, potentially through suppressing the NF-κB signaling pathway and reshaping the skin microbiota structure. This study would promote the application of GR14 as a bioactive ingredient in the fields of functional food and functional cosmetics.

12Functional roles of fish collagen peptides on bone regeneration.PubMed

Shizuka Yamada, Kohei Yamamoto, Ayako Nakazono, et al.
Fish collagen peptides (FCP) derived from the skin, bones and scales are commercially used as a functional food or dietary supplement for hypertension and diabetes. However, there is limited evidence on the effects of FCP on the osteoblast function in contrast to evidence of the effects on wound healing, diabetes and bone regeneration, which have been obtained from animal studies. In this narrative review, we expound on the availability of FCP by basic research using osteoblasts. Low-concentration FCP upregulates the expression of osteoblast proliferation, differentiation and collagen modifying enzyme-related genes. Furthermore, it could accelerate matrix mineralization. FCP may have potential utility as a biomaterial to improve collagen quality and promote mineralization through the mitogen-activated protein kinase and Smad cascades. However, there are few clinical studies on bone regeneration in human subjects. It is desirable to be applied clinically through clinical study as soon as possible, based on the results from basic research.

13Production of self-assembling biomaterials for tissue engineering.PubMed

Stuart Kyle, Amalia Aggeli, Eileen Ingham, et al.
Self-assembling peptide-based biomaterials are being developed for use as 3D tissue engineering scaffolds and for therapeutic drug-release applications. Chemical synthesis provides custom-made peptides in small quantities, but production approaches based upon transgenic organisms might be more cost-effective for large-scale peptide production. Long lead times for developing appropriate animal clones or plant lines and potential negative public opinion are obstacles to these routes. Microbes, particularly safe organisms used in the food industry, offer a more rapid route to the large-scale production of recombinant self-assembling biomaterials. In this review, recent advances and challenges in the recombinant production of collagen, elastin and de novo designed self-assembling peptides are discussed.

14Non-bioabsorbable vs. bioabsorbable membrane: assessment of their clinical efficacy in guided tissue regeneration technique. A systematic review.PubMed

Lawrence C Parrish, Takanari Miyamoto, Nelson Fong, et al.
In a 1998 review article, Laurell and colleagues performed a meta-analysis of relevant guided tissue regeneration (GTR) articles over the previous 20 years (1). The purpose of the present research was to expand on that work, particularly searching for trends discriminating between bioabsorbable and non-bioabsorbable barriers, as well as the use of enamel matrix derivative, with respect to interproximal bony defects. The most recent periodontal journals were reviewed and a search of PubMed (National Institutes of Health) was conducted via the internet covering 1990 to the present. Forty-nine articles were found to be relevant and within established parameters. The data were analyzed using (a) a variation of the methods described in Laurell et al. (1) and (b) statistics appropriate for inter-group comparisons. In most respects, all membranes and enamel matrix derivative (EMD) delivered better outcomes, in the range of 1 to 2 mm, than open flap debridement. The use of any barrier type or EMD configuration was found to yield more Clinical Attachment Level (CAL) gain than any open flap configuration. Other than collagen without grafts versus non-bioabsorbables without grafts, no other comparison between membranes or between membranes and EMD found any significant differences (P > 0.05). GTR was confirmed to be superior to open flap debridement.

15Protease-modulating matrix treatments for healing venous leg ulcers.PubMed

Maggie J Westby, Gill Norman, Jo C Dumville, et al.
BACKGROUND: Venous leg ulcers (VLUs) are open skin wounds on the lower leg that occur because of poor blood flow in the veins of the leg; leg ulcers can last from weeks to years, and are both painful and costly. Prevalence in the UK is about 2.9 cases per 10,000 people. First-line treatment for VLUs is compression therapy, but around 60% of people have unhealed ulcers after 12 weeks' treatment and about 40% after 24 weeks; therefore, there is scope for further improvement. Limited evidence suggests non-healing leg ulcers may have persisting elevated levels of proteases, which is thought to deter the later stages of healing; thus, timely protease-modulating matrix (PMM) treatments may improve healing by physically removing proteases from the wound fluid. OBJECTIVES: To determine the effects of protease-modulating matrix (PMM) treatments on the healing of venous leg ulcers, in people managed in any care setting. SEARCH METHODS: In September 2016 we searched: the Cochrane Wounds Specialised Register; CENTRAL; Ovid MEDLINE; Ovid MEDLINE (In-Process & Other Non-Indexed Citations); Ovid Embase and EBSCO CINAHL Plus. We also searched clinical trials registries for ongoing and unpublished studies, and scanned reference lists of relevant included studies as well as reviews, meta-analyses and health technology reports to identify additional studies. There were no restrictions with respect to language, date of publication or study setting. SELECTION CRITERIA: We searched for published or unpublished randomised controlled trials (RCTs) that evaluated PMM treatments for VLUs. We defined PMM treatments as those with a purposeful intent of reducing proteases. Wound healing was the primary endpoint. DATA COLLECTION AND ANALYSIS: Two review authors independently performed study selection, risk of bias assessment and data extraction. MAIN RESULTS: We included 12 studies (784 participants) in this review; sample sizes ranged from 10 to 187 participants (median 56.5). One study had three arms that were all relevant to this review and all the other studies had two arms. One study was a within-participant comparison. All studies were industry funded. Two studies provided unpublished data for healing.Nine of the included studies compared PMM treatments with other treatments and reported results for the primary outcomes. All treatments were dressings. All studies also gave the participants compression bandaging. Seven of these studies were in participants described as having 'non-responsive' or 'hard-to-heal' ulcers. Results, reported at short, medium and long durations and as time-to-event data, are summarised for the comparison of any dressing regimen incorporating PMM versus any other dressing regimen. The majority of the evidence was of low or very low certainty, and was mainly downgraded for risk of bias and imprecision.It is uncertain whether PMM dressing regimens heal VLUs quicker than non-PMM dressing regimens (low-certainty evidence from 1 trial with 100 participants) (HR 1.21, 95% CI 0.74 to 1.97).In the short term (four to eight weeks) it is unclear whether there is a difference between PMM dressing regimens and non-PMM dressing regimens in the probability of healing (very low-certainty evidence, 2 trials involving 207 participants).In the medium term (12 weeks), it is unclear whether PMM dressing regimens increase the probability of healing compared with non-PMM dressing regimens (low-certainty evidence from 4 trials with 192 participants) (RR 1.28, 95% CI 0.95 to 1.71). Over the longer term (6 months), it is also unclear whether there is a difference between PMM dressing regimens and non-PMM dressing regimens in the probability of healing (low certainty evidence, 1 trial, 100 participants) (RR 1.06, 95% CI 0.80 to 1.41).It is uncertain whether there is a difference in adverse events between PMM dressing regimens and non-PMM dressing regimens (low-certainty evidence from 5 trials, 363 participants) (RR 1.03, 95% CI 0.75 to 1.42). It is also unclear whether resource use is lower for PMM dressing regimens (low-certainty evidence, 1 trial involving 73 participants), or whether mean total costs in a German healthcare setting are different (low-certainty evidence, 1 trial in 187 participants). One cost-effectiveness analysis was not included because effectiveness was not based on complete healing. AUTHORS' CONCLUSIONS: The evidence is generally of low certainty, particularly because of risk of bias and imprecision of effects. Within these limitations, we are unclear whether PMM dressing regimens influence venous ulcer healing relative to dressing regimens without PMM activity. It is also unclear whether there is a difference in rates of adverse events between PMM and non-PMM treatments. It is uncertain whether either resource use (products and staff time) or total costs associated with PMM dressing regimens are different from those for non-PMM dressing regimens. More research is needed to clarify the impact of PMM treatments on venous ulcer healing.

16Therapeutic efficacy and concomitant toxicity of Hongsheng Dan in enhancing healing of chronic refractory wounds in rats.PubMed

JingJing Yang, QingXia Gan, Yu Yang, et al.
ETHNOPHARMACOLOGICAL RELEVANCE: Hongsheng Dan, a traditional Chinese medicine, has been utilized in China for centuries due to its therapeutic properties. Its primary active component, mercuric oxide (HgO), is known for its efficacy in extracting toxins, pus drainage, necrotic tissue removal, and tissue regeneration. Despite its longstanding clinical application, the precise therapeutic mechanisms and comprehensive safety profile of Hongsheng Dan warrant further scientific investigation. AIMS OF THE STUDY: This study aims to elucidate the therapeutic mechanisms of Hongsheng Dan in the treatment of chronic, refractory skin ulcers and to evaluate its potential toxicity risks. METHODS: A rat model of chronic refractory wound was successfully established to evaluate the therapeutic effects of Hongsheng Dan. Wound healing efficacy was systematically assessed through multiple approaches, including wound closure rate, histopathological examination, immunohistochemical and immunofluorescence staining, and Hyp content analysis. To elucidate the underlying mechanisms, qRT-PCR and WB analyses were performed. Additionally, H&E staining was conducted to examine pathological alterations in major organs, while AAS was employed to quantify mercury ion accumulation. RESULTS: Hongsheng Dan demonstrated significant wound-healing efficacy in a rat model, with optimal therapeutic outcomes observed in the medium-dose treatment group. Histopathological analysis revealed substantial improvements in wound tissue architecture, characterized by diminished inflammatory cell infiltration and enhanced collagen deposition with robust granulation tissue formation. These morphological improvements were supported by immunohistochemical evidence showing significantly upregulated VEGF expression.At the molecular level, Hongsheng Dan treatment modulated key wound-healing mediators, suppressing IL-6 while promoting Hyp synthesis, thereby facilitating extracellular matrix remodeling. Gene expression analysis revealed coordinated regulation of critical healing pathways, with upregulation of VEGF, TGF-β1, and Smad3 mRNA, concurrent with downregulation of Notch1 signaling. WB analysis confirmed these findings at the protein level, showing increased VEGF and decreased Notch1 expression.Notably, while therapeutic doses of Hongsheng Dan caused no observable histopathological abnormalities in major organs, atomic absorption spectrometry detected significant mercury accumulation in renal tissue, suggesting potential nephrotoxic risk during extended therapeutic use. CONCLUSION: This investigation adopted a dual-focused approach to evaluate both the therapeutic mechanisms and potential toxicity of Hongsheng Dan. Prior to the systematic research, we performed quality control to ascertain the mercury valence state and concentration. Following this, a chronic refractory wound model in SD rats was studied using an integrated methodological framework that combining histopathological, molecular biological, and toxicological analyses. Our findings demonstrated that Hongsheng Dan promotes chronic wound healing through multi-pathway synergistic mechanisms. Concurrent concomitant toxicity revealed mercury accumulation-related toxicity, providing crucial evidence for risk-benefit evaluation in clinical applications.

17Halofuginone to treat fibrosis in chronic graft-versus-host disease and scleroderma.PubMed

Mark Pines, David Snyder, Shai Yarkoni, et al.
Chronic graft-versus-host disease (cGvHD) and systemic sclerosis (scleroderma [SSc]) share clinical characteristics, including skin and internal organ fibrosis. Fibrosis, regardless of the cause, is characterized by extracellular matrix deposition, of which collagen type I is the major constituent. The progressive accumulation of connective tissue results in destruction of normal tissue architecture and internal organ failure. In both SSc and cGvHD, the severity of skin and internal organ fibrosis correlates with the clinical course of the disease. Thus, there is an unmet need for well-tolerated antifibrotic therapy. Halofuginone is an inhibitor of collagen type I synthesis in cells derived from various tissues and species and in animal models of fibrosis in which excess collagen is the hallmark of the disease. Halofuginone decreased collagen synthesis in the tight skin mouse (Tsk) and murine cGvHD, the 2 experimental systems that show many features resembling those of human GvHD. Inhibition of collagen synthesis by halofuginone is achieved by inhibiting transforming growth factor beta-dependent Smad3 phosphorylation. Dermal application of halofuginone caused a decrease in collagen content at the treated site of a cGvHD patient, and reduction in skin scores was observed in a pilot study with SSc patients. The results of the human studies provide basis for using halofuginone treatment for dermal fibrosis. As a first step toward future treatment of internal organ involvement, an oral administration study was performed in which halofuginone was well tolerated and plasma levels surpassed the predicted therapeutic exposure.

18High-resolution multiphoton tomography of human skin with subcellular spatial resolution and picosecond time resolution.PubMed

Karsten Konig, Iris Riemann
High-resolution four-dimensional (4-D) optical tomography of human skin based on multiphoton autofluorescence imaging and second harmonic generation (SHG) was performed with the compact femtosecond laser imaging system DermaInspect as well as a modified multiphoton microscope. Femtosecond laser pulses of 80 MHz in the spectral range of 750 to 850 nm, fast galvoscan mirrors, and a time-correlated single-photon counting module have been used to image human skin in vitro and in vivo with subcellular spatial and 250-ps temporal resolution. The nonlinear induced autofluorescence originates from naturally endogenous fluorophores and protein structures such as reduced nicotinamide adenine dinucleotide phosphate, flavins, collagen, elastin, porphyrins, and melanin. Second harmonic generation was used to detect collagen structures. Tissues of patients with dermatological disorders such as psoriasis, fungal infections, nevi, and melanomas have been investigated. Individual intratissue cells and skin structures could be clearly visualized. Intracellular components and connective tissue structures could be further characterized by fluorescence excitation spectra, by determination of the fluorescence decay per pixel, and by fluorescence lifetime imaging. The novel noninvasive multiphoton autofluorescence-SHG imaging technique provides 4-D (x,y,z,tau) optical biopsies with subcellular resolution and offers the possibility of introducing a high-resolution optical diagnostic method in dermatology.

19Influence of collagen peptide supplementation on visible signs of skin and nail health and -aging in an East Asian population: A double blind, randomized, placebo-controlled trial.PubMed

Sara Vleminckx, Nicolina Virgilio, Jerome Asserin, et al.
BACKGROUND: A healthy skin provides protection against intrinsic and extrinsic factors. Skin aging is characterized by structural and morphological alterations affecting skin health, integrity, and functionality, resulting in visible aging signs. AIM: The primary objective of this study was to assess the effect of a collagen peptide dietary supplement on skin aging in the East Asian population. METHODS: Eighty-five healthy women, aged from 43 to 65 years old, were randomly assigned to the collagen supplement (CP, 5 g) or placebo (maltodextrin, 5 g) group. To standardize daily skin care, the volunteers in both groups used a specific face cream for 28 days prior to and throughout the supplementation period, creating an equal baseline for the assessment of the efficacy of CP on several skin parameters. At baseline, day 28 and day 84, the following hallmarks of skin and nail aging were assessed: dermis density, skin moisture and elasticity, wrinkle visibility, beauty perception, and nail color. RESULTS: After 84 days, a significant improvement of dermis density and skin moisture was observed in the collagen peptides group compared to the placebo group. Positive effects on skin elasticity, wrinkle visibility, nail color, and overall beauty perception were already observed within 28 days of supplementation in the CP group, while the same effects in the placebo group were only observed after 84 days. CONCLUSION: Taken together, these results show that, in addition to a standardized skin care, daily supplementation with 5 g of collagen peptides positively affects visible signs of skin and nail aging in the East Asian population.

20Collagen peptides promote skin collagen synthesis by modulating the gut microbiota and activating the TGF-β pathway.PubMed

Haowen Zhang, Zongliang Yao, Yang Song, et al.
Collagen peptides have shown potential in improving skin conditions. Based on this, we hypothesized that the protease-resistant portion of these peptides might act as a prebiotic to enhance collagen synthesis by modulating the gut microbiota and activating the TGF-β pathway. rat models and everted gut sac experiments demonstrated that hydroxyproline-containing tripeptide-rich collagen peptides (CTP) exhibited superior absorption compared to high molecular weight collagen peptides. In a skin collagen-deficient mouse model, CTP supplementation significantly increased skin collagen content by 119.95% compared to the control group. Transcriptomic analysis showed that CTP enhanced skin collagen synthesis and inhibited inflammation-related collagen degradation through the TGF-β pathway, involving anti-inflammatory cells such as plasma cells. Gut microbiota analysis showed that CTP increased the gut microbiota α diversity (Shannon index) and altered the microbial community structure (UniFrac distances), characterized by increased abundance of short-chain fatty acid (SCFA)-producing bacteria, and , and enhanced SCFA production. These effects were linked to the delivery of Pro-Hyp to the hindgut according to metabolome analysis, promoting TGF-β-producing cells in the gut and contributing to activation of the TGF-β pathway in the skin. Overall, our study provides novel insights into the mechanism by which CTP promotes skin collagen synthesis through gut microbiota remodeling and TGF-β pathway activation, highlighting the potential of CTP to exhibit prebiotic-like properties for skin health improvement.
内容由 AI 生成,仅供参考,请仔细甄别